Does the media favor COO or HSIC?

In the previous week, Cooper Companies had 12 more articles in the media than Henry Schein. MarketBeat recorded 20 mentions for Cooper Companies and 8 mentions for Henry Schein. Cooper Companies' average media sentiment score of 1.02 beat Henry Schein's score of 0.62 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 8 Very Positive mention(s) 6 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HSIC or IDXX?

In the previous week, IDEXX Laboratories had 1 more articles in the media than Henry Schein. MarketBeat recorded 9 mentions for IDEXX Laboratories and 8 mentions for Henry Schein. IDEXX Laboratories' average media sentiment score of 1.46 beat Henry Schein's score of 0.62 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive IDEXX Laboratories 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HSIC or MMSI?

In the previous week, Merit Medical Systems had 8 more articles in the media than Henry Schein. MarketBeat recorded 16 mentions for Merit Medical Systems and 8 mentions for Henry Schein. Merit Medical Systems' average media sentiment score of 1.23 beat Henry Schein's score of 0.62 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 8 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, PODD or HSIC?

Henry Schein has higher revenue and earnings than Insulet. Henry Schein is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Insulet $2.71B 3.75 $247.10M $5.35 27.37 Henry Schein $13.18B 0.76 $398M $3.43 26.27

Is PODD or HSIC more profitable?

Insulet has a net margin of 12.29% compared to Henry Schein's net margin of 2.96%. Insulet's return on equity of 29.29% beat Henry Schein's return on equity. Company Net Margins Return on Equity Return on Assets Insulet 12.29% 29.29% 13.31% Henry Schein 2.96% 15.97% 5.56%

Does the media prefer PODD or HSIC?

In the previous week, Insulet had 29 more articles in the media than Henry Schein. MarketBeat recorded 37 mentions for Insulet and 8 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.62 beat Insulet's score of 0.20 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insulet 5 Very Positive mention(s) 1 Positive mention(s) 25 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMN or HSIC?

In the previous week, AMN Healthcare Services had 10 more articles in the media than Henry Schein. MarketBeat recorded 18 mentions for AMN Healthcare Services and 8 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.62 beat AMN Healthcare Services' score of 0.61 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 5 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Henry Schein (HSIC) Competitors

$90.12 -0.62 (-0.68%)

Closing price 08/13/2026 04:00 PM Eastern

Extended Trading

$90.46 +0.34 (+0.38%)

As of 04:17 AM Eastern

Compare

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

Should you buy Henry Schein stock or one of its competitors? Henry Schein's main competitors and comparable companies include Cooper Companies (COO), IDEXX Laboratories (IDXX), Merit Medical Systems (MMSI), Insulet (PODD), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Henry Schein compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Henry Schein (NASDAQ:HSIC) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cooper Companies has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

Henry Schein has higher revenue and earnings than Cooper Companies. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.65	$374.90M	$1.18	64.92
Henry Schein	$13.18B	0.76	$398M	$3.43	26.27

In the previous week, Cooper Companies had 12 more articles in the media than Henry Schein. MarketBeat recorded 20 mentions for Cooper Companies and 8 mentions for Henry Schein. Cooper Companies' average media sentiment score of 1.02 beat Henry Schein's score of 0.62 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	8 Very Positive mention(s)	6 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Cooper Companies has a net margin of 5.57% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Henry Schein	2.96%	15.97%	5.56%

Cooper Companies currently has a consensus target price of $81.64, suggesting a potential upside of 6.58%. Henry Schein has a consensus target price of $92.27, suggesting a potential upside of 2.38%. Given Cooper Companies' higher possible upside, equities research analysts clearly believe Cooper Companies is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47

Summary

Cooper Companies beats Henry Schein on 10 of the 17 factors compared between the two stocks.

How does Henry Schein compare to IDEXX Laboratories?

Henry Schein (NASDAQ:HSIC) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

IDEXX Laboratories has a net margin of 25.03% compared to Henry Schein's net margin of 2.96%. IDEXX Laboratories' return on equity of 71.96% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
IDEXX Laboratories	25.03%	71.96%	33.60%

Henry Schein presently has a consensus target price of $92.27, suggesting a potential upside of 2.38%. IDEXX Laboratories has a consensus target price of $747.00, suggesting a potential upside of 31.76%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe IDEXX Laboratories is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

IDEXX Laboratories has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.76	$398M	$3.43	26.27
IDEXX Laboratories	$4.30B	10.38	$1.06B	$14.22	39.87

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 0.9% of Henry Schein shares are held by company insiders. Comparatively, 0.8% of IDEXX Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Henry Schein has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market.

In the previous week, IDEXX Laboratories had 1 more articles in the media than Henry Schein. MarketBeat recorded 9 mentions for IDEXX Laboratories and 8 mentions for Henry Schein. IDEXX Laboratories' average media sentiment score of 1.46 beat Henry Schein's score of 0.62 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IDEXX Laboratories beats Henry Schein on 12 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Merit Medical Systems?

Henry Schein (NASDAQ:HSIC) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

Henry Schein currently has a consensus target price of $92.27, indicating a potential upside of 2.38%. Merit Medical Systems has a consensus target price of $100.00, indicating a potential upside of 10.50%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Merit Medical Systems	0 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Merit Medical Systems had 8 more articles in the media than Henry Schein. MarketBeat recorded 16 mentions for Merit Medical Systems and 8 mentions for Henry Schein. Merit Medical Systems' average media sentiment score of 1.23 beat Henry Schein's score of 0.62 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	8 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Merit Medical Systems	9.22%	13.75%	8.10%

Henry Schein has higher revenue and earnings than Merit Medical Systems. Henry Schein is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.76	$398M	$3.43	26.27
Merit Medical Systems	$1.58B	3.42	$128.49M	$2.42	37.40

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Merit Medical Systems beats Henry Schein on 9 of the 15 factors compared between the two stocks.

How does Henry Schein compare to Insulet?

Insulet (NASDAQ:PODD) and Henry Schein (NASDAQ:HSIC) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

96.6% of Henry Schein shares are held by institutional investors. 0.4% of Insulet shares are held by insiders. Comparatively, 0.9% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Insulet has a net margin of 12.29% compared to Henry Schein's net margin of 2.96%. Insulet's return on equity of 29.29% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	12.29%	29.29%	13.31%
Henry Schein	2.96%	15.97%	5.56%

Insulet has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, Henry Schein has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

Insulet currently has a consensus price target of $195.40, suggesting a potential upside of 33.43%. Henry Schein has a consensus price target of $92.27, suggesting a potential upside of 2.38%. Given Insulet's higher possible upside, research analysts clearly believe Insulet is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	2 Sell rating(s)	11 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.44
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47

Henry Schein has higher revenue and earnings than Insulet. Henry Schein is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.71B	3.75	$247.10M	$5.35	27.37
Henry Schein	$13.18B	0.76	$398M	$3.43	26.27

In the previous week, Insulet had 29 more articles in the media than Henry Schein. MarketBeat recorded 37 mentions for Insulet and 8 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.62 beat Insulet's score of 0.20 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	5 Very Positive mention(s)	1 Positive mention(s)	25 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Insulet beats Henry Schein on 10 of the 16 factors compared between the two stocks.

How does Henry Schein compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

AMN Healthcare Services has a net margin of 3.06% compared to Henry Schein's net margin of 2.96%. AMN Healthcare Services' return on equity of 19.92% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Henry Schein	2.96%	15.97%	5.56%

Henry Schein has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.49	-$95.70M	$2.68	12.85
Henry Schein	$13.18B	0.76	$398M	$3.43	26.27

In the previous week, AMN Healthcare Services had 10 more articles in the media than Henry Schein. MarketBeat recorded 18 mentions for AMN Healthcare Services and 8 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.62 beat AMN Healthcare Services' score of 0.61 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	5 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

AMN Healthcare Services has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

AMN Healthcare Services presently has a consensus price target of $30.86, suggesting a potential downside of 10.40%. Henry Schein has a consensus price target of $92.27, suggesting a potential upside of 2.38%. Given Henry Schein's stronger consensus rating and higher possible upside, analysts plainly believe Henry Schein is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Henry Schein beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

Get Henry Schein News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSIC vs. The Competition

Export

Metric	Henry Schein	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$10.11B	$9.89B	$7.07B	$12.99B
Dividend Yield	N/A	2.55%	2.58%	10.72%
P/E Ratio	26.27	35.30	269.63	25.21
Price / Sales	0.76	4.85	596.27	99.03
Price / Cash	11.66	124.00	70.53	50.75
Price / Book	2.63	5.32	13.13	6.24
Net Income	$398M	$309.96M	$3.45B	$347.70M
7 Day Performance	2.26%	0.25%	0.78%	0.87%
1 Month Performance	3.69%	0.66%	1.45%	0.90%
1 Year Performance	32.71%	19.91%	67.09%	20.13%

Henry Schein Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSIC Henry Schein	2.4968 of 5 stars	$90.12 -0.7%	$92.27 +2.4%	+30.6%	$10.11B	$13.18B	26.27	25,000
COO Cooper Companies	2.5451 of 5 stars	$74.23 +2.6%	$81.36 +9.6%	+3.1%	$14.10B	$4.09B	62.91	15,000	Analyst Forecast
IDXX IDEXX Laboratories	4.5611 of 5 stars	$567.84 +1.6%	$749.00 +31.9%	-14.6%	$44.10B	$4.30B	41.81	11,000	Positive News Analyst Forecast High Trading Volume
MMSI Merit Medical Systems	3.5307 of 5 stars	$85.53 +0.6%	$100.30 +17.3%	+5.0%	$5.08B	$1.52B	35.34	7,500	Positive News Analyst Forecast
PODD Insulet	4.8463 of 5 stars	$169.70 +2.6%	$233.38 +37.5%	-52.6%	$11.45B	$2.71B	39.47	5,400	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSIC) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

How does Henry Schein compare to Cooper Companies?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Summary

How does Henry Schein compare to Merit Medical Systems?

Summary

How does Henry Schein compare to Insulet?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

How does Henry Schein compare to Cooper Companies?

Do insiders and institutionals hold more shares of COO or HSIC?

Which has more volatility & risk, COO or HSIC?

Which has stronger valuation & earnings, COO or HSIC?

Does the media favor COO or HSIC?

Is COO or HSIC more profitable?

Do analysts rate COO or HSIC?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Is HSIC or IDXX more profitable?

Do analysts recommend HSIC or IDXX?

Which has better earnings and valuation, HSIC or IDXX?

Do institutionals and insiders have more ownership in HSIC or IDXX?

Which has more risk & volatility, HSIC or IDXX?

Does the media prefer HSIC or IDXX?

Summary

How does Henry Schein compare to Merit Medical Systems?

Do analysts prefer HSIC or MMSI?

Does the media refer more to HSIC or MMSI?

Which has more volatility and risk, HSIC or MMSI?

Is HSIC or MMSI more profitable?

Which has better valuation & earnings, HSIC or MMSI?

Do institutionals & insiders have more ownership in HSIC or MMSI?

Summary

How does Henry Schein compare to Insulet?

Do institutionals and insiders hold more shares of PODD or HSIC?

Is PODD or HSIC more profitable?

Which has more volatility and risk, PODD or HSIC?

Do analysts recommend PODD or HSIC?

Which has preferable valuation & earnings, PODD or HSIC?

Does the media prefer PODD or HSIC?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Is AMN or HSIC more profitable?

Which has better earnings & valuation, AMN or HSIC?

Does the media prefer AMN or HSIC?

Which has more volatility and risk, AMN or HSIC?

Do analysts recommend AMN or HSIC?

Do institutionals and insiders hold more shares of AMN or HSIC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools